Medicare Enrolled

Dr. Richard Harris, M.D.

Urology Physician · Melrose Park, IL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
501 W NORTH AVE STE 201, Melrose Park, IL 60160
7084505055
In practice since 2006 (20 years)
NPI: 1346290673 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Harris from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Harris? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Harris

Dr. Richard Harris is an urology physician in Melrose Park, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Harris performed 892 Medicare services across 543 unique beneficiaries.

Between the years covered by Open Payments, Dr. Harris received a total of $513,288 from 41 pharmaceutical and/or device companies across 641 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Harris is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 892 Medicare services $513,288 industry payments

Medicare Practice Summary

Medicare Utilization ↗
892
Medicare services
Bottom 32% in IL for urology physician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
543
Unique beneficiaries
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~45 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
193 $65 $163
Urinalysis with microscopic exam
A urine test performed manually that includes examining the sample under a microscope to check for abnormalities.
192 $3 $20
Leuprolide acetate (for depot suspension), 7.5 mg 134 $125 $1,500
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
108 $8 $20
PSA test (prostate cancer screening) 83 $18 $90
Chronic care management, first 20 min/month
This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions.
53 $42 $129
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
43 $8 $100
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
31 $27 $419
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
28 $87 $228
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
16 $188 $930
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
11 $107 $243
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$513,288
Total received (2018-2024)
Avg $73,327/year across 7 years
Top 1% in IL for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
641
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$378,921 (73.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$103,716 (20.2%)
Financial / Ownership
Ownership or investment interests, royalties, and licensing fees
$23,258 (4.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,393 (1.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$16,986
2023
$54,993
2022
$58,500
2021
$76,724
2020
$48,246
2019
$104,151
2018
$153,689

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$7,106
Merck Sharp & Dohme LLC
$5,600
Ferring Pharmaceuticals Inc.
$1,110
Janssen Scientific Affairs, LLC
$1,090
Great Lakes Medical Services, LLC
$829
Sumitomo Pharma America, Inc.
$650
Astellas Pharma US Inc
$308
Bayer Healthcare Pharmaceuticals Inc.
$248
Novartis Pharmaceuticals Corporation
$45
Top 3 companies account for 81.3% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$113,873
Astellas Pharma US Inc
$92,132
Dendreon Pharmaceuticals LLC
$42,362
Bayer HealthCare Pharmaceuticals Inc.
$40,968
Janssen Scientific Affairs, LLC
$37,667
SN Holdings, LLC
$37,326
Myovant Sciences Inc.
$34,041
Great Lakes Medical Services, LLC
$24,087
Merck Sharp & Dohme Corporation
$21,109
UroGPO LLC
$19,535
Merck Sharp & Dohme LLC
$14,629
Progenics Pharmaceuticals, Inc.
$11,181
Sumitomo Pharma America, Inc.
$9,579
Foundation Medicine, Inc.
$3,256
Blue Earth Diagnostics Limited
$3,206
Clovis Oncology, Inc.
$2,437
GENZYME CORPORATION
$1,854
Ferring Pharmaceuticals Inc.
$1,110
AstraZeneca Pharmaceuticals LP
$930
PFIZER INC.
$509
TOLMAR Pharmaceuticals, Inc.
$392
Bayer Healthcare Pharmaceuticals Inc.
$248
Avadel Specialty Pharmaceuticals, LLC
$153
Endo Pharmaceuticals Inc.
$123
AbbVie, Inc.
$104
UroGen Pharma, Inc.
$93
Coloplast Corp
$46
Antares Pharma, Inc.
$45
Novartis Pharmaceuticals Corporation
$45
NeoTract Inc.
$33
Covidien LP
$29
Boston Scientific Corporation
$24
Sun Pharmaceutical Industries Inc.
$22
Retrophin, Inc.
$22
Genentech USA, Inc.
$22
MEDIVATION FIELD SOLUTIONS LLC
$22
Osiris Therapeutics Inc.
$19
Rochester Medical Corporation
$18
Cook Incorporated
$15
Mission Pharmacal Company
$14
NxThera, Inc.
$11
Top 3 companies account for 48.4% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · Axumin · COOK MEDICAL CATHETERS · ELIGARD · ERLEADA · Erleada · FOUNDATIONACT · GENERAL BPH · GRAFIX/GRAFIXPL/STRAVIX · JELMYTO · JEVTANA · KEYTRUDA · LYNPARZA · Lupron · Lupron Depot · MYRBETRIQ · Noctiva · Non-Covered · Nubeqa · ORGOVYX · OTREXUP · Otrexup · PLUVICTO · PROVENGE · PYLARIFY · RUBRACA · Rezum · SPEEDICATH · TECENTRIQ · TOVIAZ · Uribel · UroLift · XIAFLEX · XTANDI · Xofigo · Xtandi · YONSA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (74%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for urology physician in IL.

Looking for an urology physician in Melrose Park?
Compare urology physicians in the Melrose Park area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
367
Per 100K population
7.1
County median income
$81,797
Nearest hospital
LOYOLA GOTTLIEB MEMORIAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Harris is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 1% of IL peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Harris experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Harris performed 193 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Harris receive payments from pharmaceutical companies?
Yes. Dr. Harris received a total of $513,288 from 41 companies across 641 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Harris's costs compare to other urology physicians in Melrose Park?
Dr. Harris's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Harris) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →